Top Biotech Companies (3,708)
Ataraxis is an AI precision medicine company transforming cancer diagnostics and patient outcomes through the power of AI. We are addressing previously unsolvable problems in cancer prognosis and treatment selection through cutting-edge foundation models and multi-modal data. Our first clinically validated offering, Ataraxis Breast, is the world’s first AI-native prognostic/predictive test for breast cancer and provides greater accuracy than standard...
Orion is a globally operating Nordic pharmaceutical company and builder of well-being. Rooted in Nordic values of trust and openness, the company focuses on developing treatments and conducting research to empower people to live their lives to the fullest. Operating in over 35 countries, Orion drives innovation in healthcare to improve health outcomes for millions of people worldwide.
Microbial Discovery Group (MDG) is an R&D-driven product development and Bacillus fermentation company dedicated to developing and commercializing microbial solutions for industrial and environmental applications. Focused on addressing global challenges in health, environment, and food supply, MDG strives to 'Feed, Clean, Save the World' by leveraging real science and trusted processes to provide sustainable and innovative biological solutions for its...
Founded in 2002 and listed on the Hong Kong Stock Exchange in 2015, GenScript has an established global presence across Greater China, North America, the EU, and Asia Pacific. Today, over 300,000 customers from over 160 countries and regions worldwide have used GenScript’s premier, convenient, and reliable products and services. GenScript currently has over 5,000 employees globally, 33% holding master’s...
GenScript's Top Stability & Growth Strengths
Strong Revenue Growth: Recent periods show strong top-line expansion across 2023, 2024, and H1 2025, with momentum supported by gains in Life Science Services, CDMO, and industrial synthetic biology. Forward-looking commentary indicates continued growth expectations for core segments.
Investor Backing & Capital Strength: The company reports a sizable cash position and undertook substantial investments in manufacturing and commercial capabilities in the United States and Europe. This financial strength underpins capacity expansion and supports strategic execution.
Diversified Revenue Streams: Multiple business units contribute to performance, including Life Science Services, ProBio CDMO, and industrial synthetic biology, alongside growth in a commercial cell therapy franchise. A developing synthetic biology pipeline with near-term product launches further broadens sources of revenue.
ArsenalBiosciences, Inc., is a clinical stage programmable cell therapy company focused on the realization of solid tumor cell therapy to defeat cancer. Our discovery engine comprises precise CRISPR-enabled genome editing, integrated circuits incorporating logic gates for improved tumor targeting, and therapeutic enhancements enabling multiple pharmaceutical functions. With our programmable and computationally driven approach, we aim for enhanced and broader efficacy,...
RadioMedix, Inc. is a biotechnology company, based in Houston, Texas, focused on innovative targeted radio-pharmaceuticals for diagnosis, monitoring and therapy of cancer. The company is commercializing generator-produced radio-pharmaceuticals based on Gallium-68 chemistry. RadioMedix is in late-stage development of a new radio-labeled analog targeting metabolic pathway, GlucoMedix, which is based on its patented DO2A-chelation technology. RadioMedix is introducing the SmartMedix™ automated laboratory...
> Onyx is a research collective in Berkeley, California, building a virtual immune system: a model of how real people respond to infection, inflammation, and treatment. > > > Most immune data is a snapshot. Onyx follows the same people over time and around key clinical events, such as changes in treatment, vaccination, or infection. Our members, healthy adults and people...
Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat currently incurable diseases. Aspect is creating these next generation cell therapies by applying its full-stack tissue therapeutic platform, which combines the company’s proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design. Aspect’s bioprinted tissue therapeutics are designed to replace, repair, or supplement...
We are making biology programmable to transform health and sustainability for the benefit of all. We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizing existing enzymes, and advancing genetic engineering. Contact us to work with us today.
Cyberhill Partners is the Enterprise AI Factory. We build and deploy enterprise AI solutions — fast, secure, traceable, and fully owned by you. After 7+ years building AI at the U.S. Department of Defense, we spun out that expertise to solve the hardest problems in commercial enterprise. With more than 1,000 implementations delivered and an $11M investment from Baleon Capital,...
Cyberhill Partners's Top Stability & Growth Strengths
Strong Hiring & Retention: Hiring activity is visible through open roles on the careers board and multiple recent senior and technical hires across sales, delivery operations, compliance, and AI engineering, indicating active team scaling.
Strategic Partnerships: A strategic partnership with data.world is described as supporting expansion in federal AI/data programs and is referenced alongside multiple DoD-related awards, indicating ecosystem-building for go-to-market and delivery.
Product Line Growth: A new offering (“Wolverine,” described as an AI-powered digital twin for cybersecurity stacks) signals movement beyond services into productized solutions intended to scale.
The UK Centre for Ecology & Hydrology (UKCEH) is an independent, not-for-profit research institute. Our scientists provide the data and insights that researchers, governments and businesses need to create a productive, resilient and healthy environment. We produce environmental science for a world where people and nature prosper
Magic Hat Consulting is a boutique Life Sciences consulting firm dedicated to elevating product launch success and enhancing overall commercialization.
The Bill & Melinda Gates Medical Research Institute is a non-profit organization dedicated to the development and effective use of novel biomedical interventions addressing substantial global health concerns, for which investment incentives are limited. The institute works through collaborating partners and organizations, coordinating and driving the full spectrum of biopharmaceutical development activities, including pre-clinical development, full clinical development (from phase...
Substrate Bio develops AI-native data-production infrastructure for biology by building a network of fully autonomous wet labs and cloud-based data production facilities. By integrating these facilities with foundation models, the company produces structured biological data at scale to enable AI-driven biological discovery, acting as a critical infrastructure layer for the field.
Orakl Oncology is a techbio startup and precision oncology company that combines cutting-edge biology and AI to accelerate cancer drug discovery and development. Utilizing an innovative predictive engine and one of the world's largest collections of patient tumor avatars, the company aims to de-risk clinical trials, identify new drug targets, and expand the therapeutic arsenal available to cancer patients.
Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply. With time-tested experience in development sciences, delivery technologies, and...
Catalent, Inc.'s Top Stability & Growth Strengths
Strong Market Position & Advantage: Independent analyses consistently place Catalent among the top global CDMOs, with meaningful presence in outsourced finished‑dose approvals and a broad end‑to‑end network. Its scale across oral, sterile, biologics, and cell & gene therapy supports late‑stage and commercial programs globally.
Investor Backing & Capital Strength: Novo Holdings’ completed acquisition provides deep‑capital sponsorship and strategic validation, with U.S./EU clearance reinforcing the platform’s importance. Related transactions around sterile sites highlight the strategic value of capabilities aligned to high‑demand medicines.
Future-Ready Strategy: Private ownership and a refreshed operating model aim to focus investment on biologics, cell & gene therapy, and clinical supply. GLP‑1–linked demand signals and capacity plans into the coming years indicate preparedness for sustained growth.
Coherus is a commercial-stage biopharmaceutical company focused on the research, development, and commercialization of innovative immunotherapies to treat cancer and the commercialization of our portfolio of FDA-approved therapeutics. We are building a leading oncology company backed by in-house expertise and an established infrastructure from our diversified portfolio of FDA-approved biosimilar products. If you are interested in joining a highly innovative and...
ProKidney (Nasdaq: PROK), a pioneer in the treatment of CKD through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney’s lead product candidate, REACT™ (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases potentially drive...
Lucis focuses on Function Health for Europe, aiming to address preventable chronic diseases.
Grand River Aseptic Manufacturing (GRAM) is a leading pharmaceutical contract development and manufacturing organization (CDMO) specializing in aseptic fill-finish services for biologics, small molecules, and vaccines, offering capabilities for liquid and lyophilized vials, syringes, and cartridges.
































